Key result
Maternal cytomegalovirus IgG antibody presence in the first trimester was not associated with fetal death or low birth weight.
Why the study?
Does maternal CMV antibody status in pregnancy increase the risk of fetal death and low birth weight?
Case-Control (n=1,238)
Does maternal CMV antibody status in pregnancy increase the risk of fetal death and low birth weight?
Maternal CMV infection during pregnancy does not appear to be causally related to fetal death or low birth weight.
Answers are grounded in this paper and cite their sources.
No link between first-trimester CMV IgG and fetal death or low birth weight; hypothesis-generating and should not yet change practice.
BACKGROUND: The aim of this study was to assess the impact of maternal cytomegalovirus (CMV) antibody status in pregnancy on the risk of fetal death and of low birth weight. METHODS: The study of fetal death risk was a nested case-control study. Cases were all women within a cohort of 35,940 pregnant women in Norway 1992--94, who experienced fetal death after 16th week of gestation (n=281). Controls were 957 randomly selected women with live born children. Both groups were identified through linkage to the Norwegian Medical Birth Registry. The risk of low birth weight was studied in the live born children. RESULTS: Seventy-two percent (203/281) of the cases and 69% (662/957) of the controls had CMV immunoglobulin G (IgG) antibodies in the first trimester (P=0.3). 0.4% (1/281) of the cases and 0.7% (7/957) had CMV IgM antibodies in the first trimester (P=0.7). Among 322 initially CMV antibody-negative women, 11% (6/55) of the cases and 9% (24/267) of the controls had occurrence of CMV IgG and/or IgM antibodies (P=0.7) during pregnancy. Also, after control for maternal age, parity, and follow-up time, no association between CMV antibodies and fetal death was found. CMV antibody status was not associated with low birth weight. CONCLUSIONS: This study does not support a causal relation between CMV infection in pregnancy and fetal death or low birth weight.
No takes yet. Share an insight, caveat, or question.
Eskild et al. (2005) conducted a case-control in Pregnancy (n=1,238). Maternal cytomegalovirus (CMV) antibody status vs. CMV antibody-negative status was evaluated on Fetal death (p=0.3). Maternal cytomegalovirus IgG antibody presence in the first trimester was not associated with fetal death or low birth weight.
Synapse has enriched 10 related papers. Consider them for comparative context: